NEIMETH Share Price Performance
₦5.20
3.28 (170.83%)
29.5% undervalued intrinsic discount
₦7.38
Fair Value
Price ₦5.20
Wane_Investment_House ₦7.38
Fair Value₦7.38
Share Price₦5.20
29.5% undervalued intrinsic discount
Neimeth International Pharmaceuticals Plc Stock Price
- 1 Narratives written by author
- 9 Comments on narratives written by author
- 16 Fair Values set on narratives written by author
NEIMETH Community Narratives
WA
Fair Value ₦7.38 29.5% undervalued intrinsic discount
Neimeth International Pharmaceuticals Plc – Moderate 9M 2025 Growth Amid Margin Pressure
0users have liked this narrative
9users have commented on this narrative
12users have followed this narrative
Neimeth International Pharmaceuticals Plc – Moderate 9M 2025 Growth Amid Margin Pressure
Executive Summary Neimeth International Pharmaceuticals Plc (“Neimeth” or “the Company”) reported moderate growth in revenue and profitability for the nine months ended September 30, 2025. Total revenue for the period increased 62% YoY to ₦5.01 billion , driven primarily by improved sales volumes and better market penetration.Read more
0users have liked this narrative
9users have commented on this narrative
12users have followed this narrative
WA
₦7.38
29.5% undervalued intrinsic discount
Wane_Investment_House Fair Value
Revenue growth
5% p.a.
Profit Margin
25%
Future PE
25x
Share price in 2030
₦9.41
Snowflake Analysis
Neimeth International Pharmaceuticals Plc Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -0.20
- 46.28%
- -13.38%
- 264.2%
About NEIMETH
- Founded
- 1957
- Employees
- 175
- CEO
- WebsiteView website
Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana. It provides health care, ethical, and veterinary related products; and poultry and animal range of anthelmintic products, as well as production enhancing medicaments. The company was formerly known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated in 1957 and is based in Lagos, Nigeria.